1 FLUTICASONE PROPIONATE | 20 of 520 | 5820 prescriptions Less than 1% of all prescriptions | 4450 | 2380 patients 47% of all patients | 2010 patients 39% of all patients | |
2 BREO ELLIPTA (FLUTICASONE/VILANTEROL) | 80 of 620 | 3380 prescriptions Less than 1% of all prescriptions | 2570 | 770 patients 15% of all patients | 630 patients 12% of all patients | |
3 ANORO ELLIPTA (UMECLIDINIUM BRM/VILANTEROL TR) | 40 of 570 | 2220 prescriptions Less than 1% of all prescriptions | 1910 | 370 patients 7% of all patients | < 11 | |
4 SYMBICORT (BUDESONIDE/FORMOTEROL FUMARATE) | 150 of 630 | 2040 prescriptions Less than 1% of all prescriptions | 1630 | 520 patients 10% of all patients | < 11 | |
5 AZELASTINE HCL | 10 of 150 | 2170 prescriptions Less than 1% of all prescriptions | 1780 | 970 patients 19% of all patients | 850 patients 17% of all patients | |
6 VENTOLIN HFA (ALBUTEROL SULFATE) | 80 of 650 | 2220 prescriptions Less than 1% of all prescriptions | 1550 | 930 patients 18% of all patients | 720 patients 14% of all patients | |
7 MONTELUKAST SODIUM | 200 of 660 | 1380 prescriptions Less than 1% of all prescriptions | 880 | 390 patients 8% of all patients | 270 patients 5% of all patients | |
8 SPIRIVA RESPIMAT (TIOTROPIUM BROMIDE) | 50 of 550 | 1770 prescriptions Less than 1% of all prescriptions | 1490 | 480 patients 9% of all patients | < 11 | |
9 INCRUSE ELLIPTA (UMECLIDINIUM BROMIDE) | 90 of 530 | 1820 prescriptions Less than 1% of all prescriptions | 1470 | 450 patients 9% of all patients | < 11 | |
10 IPRATROPIUM BROMIDE | 10 of 180 | 1380 prescriptions Less than 1% of all prescriptions | 1170 | 740 patients 15% of all patients | < 11 | |
11 STIOLTO RESPIMAT (TIOTROPIUM BR/OLODATEROL HCL) | 50 of 340 | 820 prescriptions Less than 1% of all prescriptions | | 190 patients 4% of all patients | < 11 | |
12 FLOVENT HFA (FLUTICASONE PROPIONATE) | 50 of 200 | 540 prescriptions Less than 1% of all prescriptions | 420 | 180 patients 4% of all patients | < 11 | |
13 TRELEGY ELLIPTA (FLUTICASONE/UMECLIDIN/VILANTER) | 110 of 380 | 700 prescriptions Less than 1% of all prescriptions | | 370 patients 7% of all patients | < 11 | |
14 ARNUITY ELLIPTA (FLUTICASONE FUROATE) | 10 of 270 | 780 prescriptions Less than 1% of all prescriptions | | 150 patients 3% of all patients | < 11 | |
15 PROAIR HFA (ALBUTEROL SULFATE) | 240 of 580 | 840 prescriptions Less than 1% of all prescriptions | 690 | 460 patients 9% of all patients | < 11 | |
16 ADVAIR DISKUS (FLUTICASONE PROPION/SALMETEROL) | 260 of 570 | 680 prescriptions Less than 1% of all prescriptions | 380 | 140 patients 3% of all patients | < 11 | |
17 PREDNISONE | 90 of 660 | 2260 prescriptions Less than 1% of all prescriptions | 1880 | 1420 patients 28% of all patients | 1170 patients 23% of all patients | |
18 SPIRIVA (TIOTROPIUM BROMIDE) | 220 of 570 | 660 prescriptions Less than 1% of all prescriptions | 530 | < 11 | < 11 | |
19 BEVESPI AEROSPHERE (GLYCOPYRROLATE/FORMOTEROL FUM) | 30 of 160 | 320 prescriptions Less than 1% of all prescriptions | 160 | < 11 | < 11 | |
20 CEFUROXIME (CEFUROXIME AXETIL) | 20 of 60 | 1040 prescriptions Less than 1% of all prescriptions | 910 | 790 patients 15% of all patients | 680 patients 13% of all patients | A |
21 ASMANEX (MOMETASONE FUROATE) | 50 of 70 | 130 prescriptions Less than 1% of all prescriptions | 130 | < 11 | < 11 | |
22 LEVALBUTEROL TARTRATE HFA (LEVALBUTEROL TARTRATE) | 20 of 60 | 240 prescriptions Less than 1% of all prescriptions | 240 | < 11 | < 11 | |
23 ESBRIET (PIRFENIDONE) | 90 of 170 | 250 prescriptions Less than 1% of all prescriptions | 250 | < 11 | < 11 | |
24 PROAIR RESPICLICK (ALBUTEROL SULFATE) | 80 of 130 | 160 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
25 ROPINIROLE HCL | 90 of 130 | 170 prescriptions Less than 1% of all prescriptions | 170 | < 11 | < 11 | |
26 QVAR REDIHALER (BECLOMETHASONE DIPROPIONATE) | 20 of 40 | 140 prescriptions Less than 1% of all prescriptions | 140 | < 11 | < 11 | |
27 AZITHROMYCIN | 290 of 500 | 340 prescriptions Less than 1% of all prescriptions | | 230 patients 5% of all patients | < 11 | A |
28 DALIRESP (ROFLUMILAST) | 230 of 340 | 140 prescriptions Less than 1% of all prescriptions | 140 | < 11 | < 11 | |
29 ARALAST NP (ALPHA-1-PROTEINASE INHIBITOR) | 20 of 20 | 120 prescriptions Less than 1% of all prescriptions | 00 | < 11 | 00 patients Less than 1% of all patients | |
30 SULFAMETHOXAZOLE-TRIMETHOPRIM (SULFAMETHOXAZOLE/TRIMETHOPRIM) | 80 of 100 | 120 prescriptions Less than 1% of all prescriptions | 120 | < 11 | < 11 | A |
31 ZEMAIRA (ALPHA-1-PROTEINASE INHIBITOR) | 30 of 30 | 110 prescriptions Less than 1% of all prescriptions | 110 | < 11 | < 11 | |
32 DOXYCYCLINE HYCLATE | 100 of 200 | 310 prescriptions Less than 1% of all prescriptions | | 270 patients 5% of all patients | < 11 | A |
33 CEFPODOXIME PROXETIL | 10 of 30 | 220 prescriptions Less than 1% of all prescriptions | | 180 patients 4% of all patients | < 11 | A |